Roswell Park

Roswell Park Best Hospital for Cancer

Roswell Park Named a U.S. News ‘Best Hospital’ For Cancer – Ranking 33 out of nearly 900 hospitals based on outcomes, patient safety, capabilities, reputation BUFFALO, N.Y. — Roswell Park Cancer Institute has been named a 2017–18 Best Hospital for cancer by U.S. News & World Report. The Buffalo, N.Y., comprehensive cancer center was ranked by the news outlet as 33rd among nearly 900 canc... »

Roswell Study and Lung Cancer Vaccine

Gov. Cuomo Announces Landmark Roswell Park Study Bringing Cuban Lung Cancer Vaccine to U.S. Patients, and Approval of Historic U.S. Government License Authorizing U.S.–Cuba Commercial Partnership to Fast-Track Biotech Development Spurred by NYS Trade Mission to Cuba in 2015, Buffalo cancer center will conduct a clinical trial with CIMAvax-EGF, groundbreaking immunotherapy for lung cancer developed... »

Lung Cancer Patients Who Stop Smoking Live Longer

Clinical interventions help patients with smoking cessation, extending survival BUFFALO, N.Y. — Tobacco cessation provided significant survival benefit for lung cancer patients who quit smoking shortly before or after diagnosis, despite the severity of the disease. Results of the Roswell Park Cancer Institute study were published in the Journal of Thoracic Oncology. Roswell Park has a unique Tobac... »

University at Buffalo and Roswell Park Establish Dental Residency Program 

New collaborative partnership offers advanced learning opportunity for dental-school graduates Roswell Park Cancer Institute (RPCI) and the University at Buffalo (UB) have been granted accreditation by the Commission on Dental Accreditation for a newly created general-practice dental residency program. Students in the one-year program will rotate between the UB Dental and RPCI Dental Services. The... »

New Research Uncovers Promising New Biomarker for Aggressiveness of Prostate Cancer

Roswell Park-led effort found increased levels of serum glutamate in both primary and metastatic prostate tumors BUFFALO — Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors. A team of investigators from three institutions, led by Shahriar Koochekpour, MD, PhD, Associate Professor of Cancer Genetics... »